Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) Shares Outstanding (Diluted Average): 2021-2025

Historic Shares Outstanding (Diluted Average) for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to $25.0 million.

  • Journey Medical's Shares Outstanding (Diluted Average) rose 21.53% to $25.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.0 million, marking a year-over-year increase of 21.53%. This contributed to the annual value of $20.4 million for FY2024, which is 12.06% up from last year.
  • Journey Medical's Shares Outstanding (Diluted Average) amounted to $25.0 million in Q3 2025, which was up 7.16% from $23.3 million recorded in Q2 2025.
  • Journey Medical's 5-year Shares Outstanding (Diluted Average) high stood at $25.0 million for Q3 2025, and its period low was $9.2 million during Q2 2021.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $20.6 million, with a median of $20.4 million in 2024.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first surged by 92.31% in 2022, then dropped by 2.36% in 2024.
  • Over the past 5 years, Journey Medical's Shares Outstanding (Diluted Average) (MRQ) stood at $10.2 million in 2021, then soared by 72.05% to $17.5 million in 2022, then increased by 4.00% to $18.2 million in 2023, then grew by 12.06% to $20.4 million in 2024, then rose by 22.16% to $25.0 million in 2025.
  • Its last three reported values are $25.0 million in Q3 2025, $23.3 million for Q2 2025, and $22.6 million during Q1 2025.